Id: acc1591
Group: 2sens
Protein: CIC
Gene Symbol: CIC
Protein Id: Q96RK0
Protein Name: CIC_HUMAN
PTM: phosphorylation
Site: Tyr1455
Site Sequence: SSPASSSASAATSFSLGSGTF
Disease Category: Cancer
Disease: Glioma
Disease Subtype:
Disease Cellline: GSC-7-2?
Disease Info:
Drug: dasatinib
Drug Info: "Dasatinib is a tyrosine kinase inhibitor that targets BCR-ABL and SRC family kinases, used in the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL), particularly in patients resistant or intolerant to prior therapy including imatinib."
Effect: modulate
Effect Info: "The Src inhibitor dasatinib can prevent EGF-mediated tyrosine phosphorylation of CIC, thereby reducing the survival rate of GBM cells and glioma stem cells (GSC)."
Note:
Score: 4.0
Pubmed(PMID): 32029440
Sentence Index:
Sentence:

Sequence & Structure:

MKPMKKACTGLSGPGSGSKSPPATRAKALRRRGAGEGDKPEEEDDEAQQPQPQSGPEEAEEGEEEEAERGPGAEGPPLELHPGDPAPGPAEDPKGDGEAGRWEPSLSRKTATFKSRAPKKKYVEEHGAGSSGVAGAPEERVRTPEEASGLGVPPRPPTSTRSSSTDTASEHSADLEDEPAEACGPGPWPPGSTSGSYDLRQLRSQRVLARRGDGLFLPAVVRQVRRSQDLGVQFPGDRALTFYEGVPGAGVDVVLDATPPPGALVVGTAVCTCVEPGVAAYREGVVVEVATKPAAYKVRLSPGPSSQPGLPGSLPQPPQPLHREPEEAVWVARSSLRLLRPPWEPETMLRKPPTGPEEEQAEPGATLPPCPAALDPKQPEDAEVSKISFGGNLGTHCEEGEEKHPPALGTPALLPLPPPQLLSPPPKSPAFVGPGRPGEQPSPCQEGSQGGSRSSSVASLEKGTAPAARARTPLTAAQQKYKKGDVVCTPSGIRKKFNGKQWRRLCSRDGCMKESQRRGYCSRHLSMRTKEMEGLADSGPGGAGRPAAVAAREGSTEFDWGDETSRDSEASSVAARGDSRPRLVAPADLSRFEFDECEAAVMLVSLGSSRSGTPSFSPVSTQSPFSPAPSPSPSPLFGFRPANFSPINASPVIQRTAVRSRHLSASTPKAGVLTPPDLGPHPPPPAPRERHSSGILPTFQTNLTFTVPISPGRRKTELLPHPGALGAPGAGGGGAAPDFPKSDSLDSGVDSVSHTPTPSTPAGFRAVSPAVPFSRSRQPSPLLLLPPPAGLTSDPGPSVRRVPAVQRDSPVIVRNPDVPLPSKFPGEVGTAGEVRAGGPGRGCRETPVPPGVASGKPGLPPPLPAPVPITVPPAAPTAVAQPMPAFGLASSPFQPVAFHPSPAALLPVLVPSSYTSHPAPKKEVIMGRPGTVWTNVEPRSVAVFPWHSLVPFLAPSQPDPSVQPSEAQQPASHPVASNQSKEPAESAAVAHERPPGGTGSADPERPPGATCPESPGPGPPHPLGVVESGKGPPPTTEEEASGPPGEPRLDSETESDHDDAFLSIMSPEIQLPLPPGKRRTQSLSALPKERDSSSEKDGRSPNKREKDHIRRPMNAFMIFSKRHRALVHQRHPNQDNRTVSKILGEWWYALGPKEKQKYHDLAFQVKEAHFKAHPDWKWCNKDRKKSSSEAKPTSLGLAGGHKETRERSMSETGTAAAPGVSSELLSVAAQTLLSSDTKAPGSSSCGAERLHTVGGPGSARPRAFSHSGVHSLDGGEVDSQALQELTQMVSGPASYSGPKPSTQYGAPGPFAAPGEGGALAATGRPPLLPTRASRSQRAASEDMTSDEERMVICEEEGDDDVIADDGFGTTDIDLKCKERVTDSESGDSSGEDPEGNKGFGRKVFSPVIRSSFTHCRPPLDPEPPGPPDPPVAFGKGYGSAPSSSASSPASSSASAATSFSLGSGTFKAQESGQGSTAGPLRPPPPGAGGPATPSKATRFLPMDPATFRRKRPESVGGLEPPGPSVIAAPPSGGGNILQTLVLPPNKEEQEGGGARVPSAPAPSLAYGAPAAPLSRPAATMVTNVVRPVSSTPVPIASKPFPTSGRAEASPNDTAGARTEMGTGSRVPGGSPLGVSLVYSDKKSAAATSPAPHLVAGPLLGTVGKAPATVTNLLVGTPGYGAPAPPAVQFIAQGAPGGGTTAGSGAGAGSGPNGPVPLGILQPGALGKAGGITQVQYILPTLPQQLQVAPAPAPAPGTKAAAPSGPAPTTSIRFTLPPGTSTNGKVLAATAPTPGIPILQSVPSAPPPKAQSVSPVQAPPPGGSAQLLPGKVLVPLAAPSMSVRGGGAGQPLPLVSPPFSVPVQNGAQPPSKIIQLTPVPVSTPSGLVPPLSPATLPGPTSQPQKVLLPSSTRITYVQSAGGHALPLGTSPASSQAGTVTSYGPTSSVALGFTSLGPSGPAFVQPLLSAGQAPLLAPGQVGVSPVPSPQLPPACAAPGGPVITAFYSGSPAPTSSAPLAQPSQAPPSLVYTVATSTTPPAATILPKGPPAPATATPAPTSPFPSATAGSMTYSLVAPKAQRPSPKAPQKVKAAIASIPVGSFEAGASGRPGPAPRQPLEPGPVREPTAPESELEGQPTPPAPPPLPETWTPTARSSPPLPPPAEERTSAKGPETMASKFPSSSSDWRVPGQGLENRGEPPTPPSPAPAPAVAPGGSSESSSGRAAGDTPERKEAAGTGKKVKVRPPPLKKTFDSVDNRVLSEVDFEERFAELPEFRPEEVLPSPTLQSLATSPRAILGSYRKKRKNSTDLDSAPEDPTSPKRKMRRRSSCSSEPNTPKSAKCEGDIFTFDRTGTEAEDVLGELEYDKVPYSSLRRTLDQRRALVMQLFQDHGFFPSAQATAAFQARYADIFPSKVCLQLKIREVRQKIMQAATPTEQPPGAEAPLPVPPPTGTAAAPAPTPSPAGGPDPTSPSSDSGTAQAAPPLPPPPESGPGQPGWEGAPQPSPPPPGPSTAATGR

Select PDB:

Known Drugs:

source: Multi-Sources

(see table)

No data.

Protein Tractability:

source: Open Targets
Small molecule
Antibody
PROTAC
Other modalities
Approved Drug
Advanced Clinical
Phase 1 Clinical
Structure with Ligand
High-Quality Ligand
High-Quality Pocket
Med-Quality Pocket
Druggable Family
Approved Drug
Advanced Clinical
Phase 1 Clinical
UniProt loc high conf
GO CC high conf
UniProt loc med conf
UniProt SigP or TMHMM
GO CC med conf
Human Protein Atlas loc
Approved Drug
Advanced Clinical
Phase 1 Clinical
Literature
UniProt Ubiquitination
Database Ubiquitination
Half-life Data
Small Molecule Binder
Approved Drug
Advanced Clinical
Phase 1 Clinical

PTM Intensity:

source: CPTAC

No intensity data of this site,
show all other sites!

CIC-Ser1082
Cancer Intensity
BRCA 1.268
COAD -0.144
HGSC 0.597
ccRCC 0.104
GBM 0.002
HNSC -1.032
LUAD 0.484
LUSC 0.722
non_ccRCC 0.474
PDAC -0.034
UCEC -2.441
CIC-Ser1084
Cancer Intensity
BRCA
COAD 0.707
HGSC -0.707
ccRCC
GBM
HNSC
LUAD
LUSC
non_ccRCC
PDAC
UCEC
CIC-Ser1186
Cancer Intensity
BRCA
COAD 0.573
HGSC 0.582
ccRCC -1.155
GBM
HNSC
LUAD
LUSC
non_ccRCC
PDAC
UCEC
CIC-Ser1188
Cancer Intensity
BRCA
COAD 0.707
HGSC -0.707
ccRCC
GBM
HNSC
LUAD
LUSC
non_ccRCC
PDAC
UCEC
CIC-Ser12
Cancer Intensity
BRCA
COAD
HGSC
ccRCC -0.911
GBM -0.641
HNSC 1.852
LUAD 0.043
LUSC
non_ccRCC 0.196
PDAC -0.539
UCEC
CIC-Ser1208
Cancer Intensity
BRCA
COAD
HGSC
ccRCC 0.196
GBM
HNSC 0.712
LUAD 0.556
LUSC
non_ccRCC
PDAC
UCEC -1.465
CIC-Ser1210
Cancer Intensity
BRCA
COAD -0.354
HGSC -1.421
ccRCC -0.139
GBM
HNSC 1.003
LUAD 0.911
LUSC
non_ccRCC
PDAC
UCEC
CIC-Ser1226
Cancer Intensity
BRCA 1.204
COAD
HGSC
ccRCC -1.018
GBM
HNSC
LUAD -0.591
LUSC 0.406
non_ccRCC
PDAC
UCEC
CIC-Ser1258
Cancer Intensity
BRCA -0.289
COAD 1.855
HGSC -1.398
ccRCC -0.416
GBM -0.084
HNSC 1.591
LUAD -0.251
LUSC -0.321
non_ccRCC 0.505
PDAC -0.013
UCEC -1.179
CIC-Ser1340
Cancer Intensity
BRCA -0.14
COAD 0.013
HGSC -2.948
ccRCC 0.335
GBM 0.277
HNSC 0.287
LUAD 0.403
LUSC 0.485
non_ccRCC 0.557
PDAC 0.515
UCEC 0.216
CIC-Ser1345
Cancer Intensity
BRCA
COAD 0.818
HGSC -1.115
ccRCC
GBM
HNSC
LUAD
LUSC
non_ccRCC
PDAC
UCEC 0.297
CIC-Ser1405
Cancer Intensity
BRCA
COAD -0.071
HGSC 2.368
ccRCC 0.397
GBM 0.082
HNSC -0.285
LUAD -0.137
LUSC 0.377
non_ccRCC -1.218
PDAC -0.337
UCEC -1.175
CIC-Ser1475
Cancer Intensity
BRCA
COAD
HGSC
ccRCC
GBM
HNSC 0.707
LUAD -0.707
LUSC
non_ccRCC
PDAC
UCEC
CIC-Ser1514
Cancer Intensity
BRCA 1.947
COAD -0.551
HGSC
ccRCC -1.182
GBM -0.038
HNSC 0.708
LUAD -0.305
LUSC 0.941
non_ccRCC -1.079
PDAC 0.399
UCEC -0.84
CIC-Ser1524
Cancer Intensity
BRCA
COAD
HGSC
ccRCC -1.015
GBM -0.205
HNSC 1.679
LUAD -0.188
LUSC
non_ccRCC
PDAC
UCEC -0.271
CIC-Ser1531
Cancer Intensity
BRCA
COAD
HGSC
ccRCC -0.707
GBM
HNSC 0.707
LUAD
LUSC
non_ccRCC
PDAC
UCEC
CIC-Ser16
Cancer Intensity
BRCA
COAD -0.798
HGSC
ccRCC -0.896
GBM 1.575
HNSC 0.215
LUAD -0.503
LUSC
non_ccRCC 1.124
PDAC
UCEC -0.718
CIC-Ser1609
Cancer Intensity
BRCA 0.155
COAD -0.142
HGSC -2.235
ccRCC -0.091
GBM 0.476
HNSC -0.089
LUAD 0.122
LUSC -0.657
non_ccRCC
PDAC 1.58
UCEC 0.882
CIC-Ser1630
Cancer Intensity
BRCA -0.09
COAD 0.219
HGSC -2.641
ccRCC 0.202
GBM 0.405
HNSC 0.977
LUAD
LUSC 0.219
non_ccRCC 0.533
PDAC 0.57
UCEC -0.394
CIC-Ser18
Cancer Intensity
BRCA
COAD
HGSC
ccRCC 0.819
GBM 0.943
HNSC 0.704
LUAD -1.444
LUSC
non_ccRCC
PDAC -0.922
UCEC -0.099
CIC-Ser1811
Cancer Intensity
BRCA
COAD
HGSC
ccRCC -0.545
GBM 1.347
HNSC
LUAD 0.787
LUSC
non_ccRCC -0.858
PDAC
UCEC -0.731
CIC-Ser1813
Cancer Intensity
BRCA
COAD 0.219
HGSC -2.181
ccRCC 0.215
GBM 0.831
HNSC
LUAD 0.648
LUSC
non_ccRCC 0.113
PDAC
UCEC 0.155
CIC-Ser1855
Cancer Intensity
BRCA
COAD 0.816
HGSC 1.736
ccRCC -0.443
GBM -1.005
HNSC 0.102
LUAD -0.459
LUSC -0.605
non_ccRCC 1.341
PDAC -0.18
UCEC -1.303
CIC-Ser1891
Cancer Intensity
BRCA
COAD -0.707
HGSC
ccRCC
GBM
HNSC 0.707
LUAD
LUSC
non_ccRCC
PDAC
UCEC
CIC-Ser20
Cancer Intensity
BRCA 0.676
COAD -0.234
HGSC 1.538
ccRCC
GBM 0.005
HNSC -0.014
LUAD
LUSC
non_ccRCC -1.992
PDAC -0.267
UCEC 0.287
CIC-Ser2059
Cancer Intensity
BRCA
COAD -0.707
HGSC
ccRCC
GBM
HNSC
LUAD
LUSC
non_ccRCC
PDAC
UCEC 0.707
CIC-Ser2100
Cancer Intensity
BRCA 0.707
COAD
HGSC
ccRCC
GBM
HNSC
LUAD -0.707
LUSC
non_ccRCC
PDAC
UCEC
CIC-Ser2155
Cancer Intensity
BRCA 0.88
COAD 0.208
HGSC -1.088
ccRCC
GBM
HNSC
LUAD
LUSC
non_ccRCC
PDAC
UCEC
CIC-Ser2203
Cancer Intensity
BRCA 0.733
COAD 0.403
HGSC -2.939
ccRCC 0.03
GBM 0.475
HNSC 0.043
LUAD 0.243
LUSC 0.346
non_ccRCC -0.041
PDAC 0.303
UCEC 0.403
CIC-Ser2253
Cancer Intensity
BRCA -0.395
COAD
HGSC 1.586
ccRCC 0.213
GBM 0.822
HNSC 0.662
LUAD -0.774
LUSC 0.085
non_ccRCC -2.134
PDAC 0.015
UCEC -0.08
CIC-Ser2260
Cancer Intensity
BRCA
COAD
HGSC -1.209
ccRCC -0.868
GBM
HNSC
LUAD 0.256
LUSC 1.087
non_ccRCC
PDAC
UCEC 0.733
CIC-Ser227
Cancer Intensity
BRCA 0.824
COAD 0.662
HGSC -2.211
ccRCC -0.003
GBM 0.377
HNSC 0.364
LUAD 0.539
LUSC 0.625
non_ccRCC -1.598
PDAC 0.654
UCEC -0.233
CIC-Ser2282
Cancer Intensity
BRCA -0.993
COAD 0.027
HGSC -0.725
ccRCC 0.909
GBM 2.02
HNSC -0.342
LUAD -0.313
LUSC 0.881
non_ccRCC -0.494
PDAC 0.483
UCEC -1.453
CIC-Ser2287
Cancer Intensity
BRCA
COAD -0.707
HGSC
ccRCC
GBM
HNSC
LUAD
LUSC
non_ccRCC
PDAC
UCEC 0.707
CIC-Ser2291
Cancer Intensity
BRCA 0.173
COAD -0.182
HGSC 1.427
ccRCC 0.486
GBM 1.27
HNSC -0.1
LUAD -0.865
LUSC 0.86
non_ccRCC -1.362
PDAC -0.066
UCEC -1.641
CIC-Ser2298
Cancer Intensity
BRCA
COAD -0.546
HGSC 1.154
ccRCC
GBM
HNSC
LUAD
LUSC
non_ccRCC
PDAC -0.608
UCEC
CIC-Ser2306
Cancer Intensity
BRCA
COAD 0.352
HGSC -1.772
ccRCC 0.396
GBM
HNSC
LUAD 0.343
LUSC
non_ccRCC
PDAC
UCEC 0.681
CIC-Ser2311
Cancer Intensity
BRCA
COAD 0.225
HGSC -1.751
ccRCC 0.469
GBM
HNSC 0.757
LUAD 0.3
LUSC
non_ccRCC
PDAC
UCEC
CIC-Ser2318
Cancer Intensity
BRCA 1.132
COAD 0.012
HGSC -2.597
ccRCC
GBM -0.143
HNSC 0.772
LUAD 0.017
LUSC -0.044
non_ccRCC 0.133
PDAC 0.559
UCEC 0.16
CIC-Ser2327
Cancer Intensity
BRCA 1.217
COAD -1.226
HGSC
ccRCC 0.368
GBM 0.288
HNSC 0.61
LUAD -0.047
LUSC 0.729
non_ccRCC -2.148
PDAC 0.465
UCEC -0.256
CIC-Ser2328
Cancer Intensity
BRCA 1.783
COAD 0.867
HGSC 0.325
ccRCC 0.431
GBM -1.244
HNSC -0.138
LUAD -0.407
LUSC -0.187
non_ccRCC -1.888
PDAC 0.645
UCEC -0.188
CIC-Ser2330
Cancer Intensity
BRCA
COAD -0.707
HGSC 0.707
ccRCC
GBM
HNSC
LUAD
LUSC
non_ccRCC
PDAC
UCEC
CIC-Ser2331
Cancer Intensity
BRCA
COAD
HGSC
ccRCC
GBM
HNSC
LUAD -0.707
LUSC
non_ccRCC
PDAC
UCEC 0.707
CIC-Ser301
Cancer Intensity
BRCA 0.196
COAD -1.544
HGSC -0.89
ccRCC -0.749
GBM 1.08
HNSC 0.43
LUAD -1.147
LUSC 1.127
non_ccRCC 0.249
PDAC 1.475
UCEC -0.227
CIC-Ser305
Cancer Intensity
BRCA
COAD
HGSC -1.695
ccRCC 0.212
GBM 1.394
HNSC 0.33
LUAD -0.143
LUSC
non_ccRCC
PDAC
UCEC -0.098
CIC-Ser306
Cancer Intensity
BRCA
COAD 1.214
HGSC
ccRCC -0.174
GBM
HNSC 0.172
LUAD -1.211
LUSC
non_ccRCC
PDAC
UCEC
CIC-Ser423
Cancer Intensity
BRCA -0.077
COAD
HGSC
ccRCC 0.003
GBM -2.21
HNSC 0.705
LUAD -0.358
LUSC 1.026
non_ccRCC -0.262
PDAC 1.167
UCEC 0.006
CIC-Ser428
Cancer Intensity
BRCA 1.349
COAD
HGSC
ccRCC 0.058
GBM -1.139
HNSC 0.449
LUAD -1.046
LUSC -1.296
non_ccRCC -0.076
PDAC 0.373
UCEC 1.327
CIC-Ser442
Cancer Intensity
BRCA 0.025
COAD 0.281
HGSC 1.886
ccRCC -0.175
GBM -0.225
HNSC -0.344
LUAD -1.041
LUSC -1.474
non_ccRCC 0.159
PDAC -0.657
UCEC 1.566
CIC-Ser448
Cancer Intensity
BRCA
COAD 0.89
HGSC
ccRCC
GBM
HNSC
LUAD
LUSC
non_ccRCC
PDAC -1.082
UCEC 0.192
CIC-Ser452
Cancer Intensity
BRCA
COAD 0.982
HGSC -1.017
ccRCC
GBM
HNSC
LUAD
LUSC
non_ccRCC
PDAC 0.035
UCEC
CIC-Ser454
Cancer Intensity
BRCA
COAD
HGSC
ccRCC -0.298
GBM
HNSC 0.481
LUAD 1.063
LUSC
non_ccRCC
PDAC
UCEC -1.245
CIC-Ser455
Cancer Intensity
BRCA
COAD
HGSC
ccRCC -0.865
GBM
HNSC 1.095
LUAD -0.23
LUSC
non_ccRCC
PDAC
UCEC
CIC-Ser456
Cancer Intensity
BRCA 0.188
COAD
HGSC -2.317
ccRCC 0.516
GBM 0.719
HNSC 0.611
LUAD -0.051
LUSC
non_ccRCC -0.731
PDAC 0.942
UCEC 0.122
CIC-Ser459
Cancer Intensity
BRCA
COAD
HGSC -2.427
ccRCC 0.372
GBM
HNSC 0.511
LUAD 0.393
LUSC 0.468
non_ccRCC -0.086
PDAC 0.516
UCEC 0.253
CIC-Ser54
Cancer Intensity
BRCA 0.48
COAD
HGSC -1.767
ccRCC
GBM 0.32
HNSC
LUAD 0.679
LUSC 0.288
non_ccRCC
PDAC
UCEC
CIC-Ser555
Cancer Intensity
BRCA
COAD
HGSC -1.458
ccRCC 0.161
GBM
HNSC 0.583
LUAD
LUSC 0.714
non_ccRCC
PDAC
UCEC
CIC-Ser565
Cancer Intensity
BRCA
COAD -1.024
HGSC -0.943
ccRCC 1.211
GBM
HNSC 1.141
LUAD 0.141
LUSC
non_ccRCC -0.525
PDAC
UCEC
CIC-Ser664
Cancer Intensity
BRCA -0.61
COAD -0.193
HGSC 2.881
ccRCC -0.508
GBM -0.24
HNSC -0.375
LUAD -0.754
LUSC 0.237
non_ccRCC -0.458
PDAC 0.026
UCEC -0.007
CIC-Ser693
Cancer Intensity
BRCA
COAD
HGSC
ccRCC
GBM
HNSC 0.707
LUAD -0.707
LUSC
non_ccRCC
PDAC
UCEC
CIC-Ser710
Cancer Intensity
BRCA 0.618
COAD
HGSC
ccRCC
GBM 1.077
HNSC -0.95
LUAD -0.745
LUSC
non_ccRCC
PDAC
UCEC
CIC-Ser753
Cancer Intensity
BRCA
COAD
HGSC
ccRCC 0.802
GBM
HNSC -1.12
LUAD 0.318
LUSC
non_ccRCC
PDAC
UCEC
CIC-Ser768
Cancer Intensity
BRCA 0.309
COAD -0.108
HGSC 2.808
ccRCC 0.122
GBM -0.292
HNSC -0.442
LUAD -0.244
LUSC -0.08
non_ccRCC -0.503
PDAC -1.067
UCEC -0.504
CIC-Ser776
Cancer Intensity
BRCA -0.75
COAD
HGSC
ccRCC 0.089
GBM
HNSC 0.392
LUAD -0.127
LUSC -0.266
non_ccRCC -1.497
PDAC 0.181
UCEC 1.978
CIC-Ser780
Cancer Intensity
BRCA -1.036
COAD -0.018
HGSC -1.574
ccRCC 0.029
GBM 2.248
HNSC 0.278
LUAD 0.027
LUSC 0.319
non_ccRCC -0.896
PDAC -0.018
UCEC 0.64
CIC-Ser809
Cancer Intensity
BRCA -0.678
COAD -0.509
HGSC 2.647
ccRCC -0.274
GBM -0.747
HNSC -0.069
LUAD -0.178
LUSC 1.044
non_ccRCC -0.362
PDAC -0.385
UCEC -0.487
CIC-Thr1080
Cancer Intensity
BRCA
COAD
HGSC
ccRCC -0.543
GBM
HNSC 1.154
LUAD -0.611
LUSC
non_ccRCC
PDAC
UCEC
CIC-Thr1212
Cancer Intensity
BRCA
COAD -0.148
HGSC
ccRCC -1.038
GBM
HNSC 1.367
LUAD -0.181
LUSC
non_ccRCC
PDAC
UCEC
CIC-Thr1214
Cancer Intensity
BRCA
COAD
HGSC
ccRCC -1.154
GBM
HNSC 0.601
LUAD 0.553
LUSC
non_ccRCC
PDAC
UCEC
CIC-Thr1344
Cancer Intensity
BRCA
COAD 0.566
HGSC -1.73
ccRCC 0.53
GBM
HNSC 0.639
LUAD
LUSC
non_ccRCC
PDAC
UCEC -0.005
CIC-Thr143
Cancer Intensity
BRCA -0.066
COAD
HGSC
ccRCC -0.342
GBM
HNSC 1.779
LUAD 0.23
LUSC -0.365
non_ccRCC -1.236
PDAC
UCEC
CIC-Thr1476
Cancer Intensity
BRCA
COAD
HGSC
ccRCC 0.707
GBM
HNSC -0.707
LUAD
LUSC
non_ccRCC
PDAC
UCEC
CIC-Thr1492
Cancer Intensity
BRCA -0.593
COAD 0.077
HGSC 2.787
ccRCC -0.281
GBM -0.559
HNSC 0.082
LUAD -0.816
LUSC -0.722
non_ccRCC -0.425
PDAC 0.27
UCEC 0.181
CIC-Thr1613
Cancer Intensity
BRCA
COAD 0.707
HGSC -0.707
ccRCC
GBM
HNSC
LUAD
LUSC
non_ccRCC
PDAC
UCEC
CIC-Thr2126
Cancer Intensity
BRCA
COAD
HGSC
ccRCC
GBM
HNSC
LUAD
LUSC
non_ccRCC -0.707
PDAC
UCEC 0.707
CIC-Thr2137
Cancer Intensity
BRCA
COAD -0.083
HGSC -1.296
ccRCC
GBM 1.115
HNSC
LUAD
LUSC
non_ccRCC
PDAC
UCEC 0.264
CIC-Thr2149
Cancer Intensity
BRCA
COAD
HGSC -0.707
ccRCC
GBM
HNSC
LUAD
LUSC
non_ccRCC
PDAC 0.707
UCEC
CIC-Thr2200
Cancer Intensity
BRCA 1.384
COAD
HGSC
ccRCC -1.556
GBM 0.329
HNSC -1.142
LUAD -0.524
LUSC -0.074
non_ccRCC 0.173
PDAC 0.016
UCEC 1.393
CIC-Thr2227
Cancer Intensity
BRCA
COAD
HGSC -1.044
ccRCC
GBM
HNSC
LUAD -0.316
LUSC 1.345
non_ccRCC
PDAC
UCEC 0.015
CIC-Thr2250
Cancer Intensity
BRCA
COAD
HGSC
ccRCC 0.707
GBM
HNSC
LUAD -0.707
LUSC
non_ccRCC
PDAC
UCEC
CIC-Thr2290
Cancer Intensity
BRCA
COAD 0.238
HGSC 0.184
ccRCC -0.119
GBM 1.236
HNSC
LUAD
LUSC
non_ccRCC
PDAC
UCEC -1.539
CIC-Thr2307
Cancer Intensity
BRCA
COAD 0.27
HGSC -1.973
ccRCC 0.589
GBM
HNSC 0.754
LUAD 0.346
LUSC
non_ccRCC
PDAC
UCEC 0.014
CIC-Thr2317
Cancer Intensity
BRCA
COAD -0.037
HGSC -1.933
ccRCC 0.055
GBM 1.478
HNSC 0.06
LUAD 0.206
LUSC
non_ccRCC
PDAC
UCEC 0.172
CIC-Thr24
Cancer Intensity
BRCA
COAD -0.707
HGSC 0.707
ccRCC
GBM
HNSC
LUAD
LUSC
non_ccRCC
PDAC
UCEC
CIC-Thr410
Cancer Intensity
BRCA
COAD
HGSC
ccRCC
GBM
HNSC
LUAD -0.707
LUSC
non_ccRCC 0.707
PDAC
UCEC
CIC-Thr472
Cancer Intensity
BRCA -0.116
COAD -0.059
HGSC 2.968
ccRCC -0.241
GBM -0.465
HNSC -0.219
LUAD -0.47
LUSC -0.193
non_ccRCC -0.664
PDAC -0.203
UCEC -0.338
CIC-Thr556
Cancer Intensity
BRCA
COAD
HGSC -1.153
ccRCC 0.515
GBM
HNSC 0.637
LUAD
LUSC
non_ccRCC
PDAC
UCEC
CIC-Thr564
Cancer Intensity
BRCA
COAD -0.803
HGSC -1.043
ccRCC 1.263
GBM
HNSC 1.123
LUAD 0.094
LUSC
non_ccRCC -0.634
PDAC
UCEC
CIC-Thr674
Cancer Intensity
BRCA -0.082
COAD 0.406
HGSC 0.684
ccRCC -0.622
GBM 2.098
HNSC 0.142
LUAD -0.684
LUSC -0.259
non_ccRCC -1.768
PDAC 0.709
UCEC -0.624
CIC-Thr698
Cancer Intensity
BRCA -0.394
COAD
HGSC
ccRCC 1.036
GBM
HNSC -1.521
LUAD 0.631
LUSC 0.247
non_ccRCC
PDAC
UCEC
CIC-Thr701
Cancer Intensity
BRCA
COAD
HGSC
ccRCC
GBM
HNSC 0.707
LUAD -0.707
LUSC
non_ccRCC
PDAC
UCEC
CIC-Thr755
Cancer Intensity
BRCA
COAD -0.707
HGSC 0.707
ccRCC
GBM
HNSC
LUAD
LUSC
non_ccRCC
PDAC
UCEC
CIC-Tyr2299
Cancer Intensity
BRCA
COAD -0.707
HGSC 0.707
ccRCC
GBM
HNSC
LUAD
LUSC
non_ccRCC
PDAC
UCEC

PTM-Disease Association:

source: PTMD
Residue Position State Disease Class PMID
Y 1455 U Glioblastoma Phosphorylation 32029440

State Note: Based on the distinct PTM states in diseases, PTMD classified all disease-associated PTMs into six classes, including whether the up-regulation (U) or down-regulation (D) of PTM levels, the absence (A) or presence (P) of PTMs, and the creation (C) or disruption (N) of PTM sites are associated with diseases.

PTM-Drug Perturbation Response:

source: DecryptM

No data.

Function score:

source: funscoR

No data.

Cross Links: